Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation
Carolina Simioni(University of Ferrara), Luca M. Neri(University of Ferrara)
Cited by 62
Related Papers
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging
|Oncotarget|2018|510
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia
|Leukemia|2012|87
Threonine 308 phosphorylated form of akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin
|Journal of Cellular Physiology|2003|70